Bethesda system for reporting thyroid cytopathology

Last revised by Henry Knipe on 20 Mar 2025

The Bethesda system for reporting thyroid cytopathology comprises six categories of pathological reporting of thyroid FNA, with each category linked to a malignancy risk.

The Bethesda system was first published in 2010 and subsequently revised with the third edition published in 2023 to align with the 2022 WHO classification of thyroid tumors 3.

  • category I: non-diagnostic

  • category II: benign

  • category III: atypia of undetermined significance

  • category IV: suspicious for follicular neoplasm

  • category V: suspicious for malignancy

  • category VI: malignant

Cases and figures

  • Case 1: category V lesion
  • Case 2: category II lesion
:

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.